摘要Objective: Curcumin(Cur) and Chitosan(CS) were utilized as primary components for the production of curcumin chitosan nanoparticles. The impact of these nanoparticles on oxidative stress in mycoplasma pneumoniae-infected mice was assessed. Methods: The drug loading and entrapment efficiency of Cur-CS nanoparticles were determined for various feeding ratios, and the release profiles of Cur-CS nanoparticles in different release media were investigated using the dynamic membrane dialysis method. The mycoplasma pneumoniae pneumonia(MPP) mouse model was created through the infection of mice with mycoplasma pneumoniae. The mice were then allocated randomly into five groups: a blank control group, an MPP model group, a low Cur-CS dose group, a middle Cur-CS dose group, and a high Cur-CS dose group, each consisting of 7 mice. The study compared the levels of antioxidant enzymes and phospholipid peroxide content in the lung tissue of mice across various experimental groups. Results: The findings indicated that the drug loading of nanoparticles escalated from 2.10% to 11.74% as the feed ratio of Cur to CS increased from 1∶ 20 to 1∶ 2.5. Concurrently, as drug loading increased, the entrapment efficiency of nanoparticles decreased from 85.33% to 58.92%. The cumulative release rate of Cur was 95.3% after 24 h, whereas the cumulative release rate of Cur-CS nanoparticles was only 94.3% after 48 h. Analysis of the lung tissue samples indicated that the levels of SOD [(76.17±9.36) U/ml, (86.23±10.09) U/ml, (98.06±11.12) U/ml] and GSH-Px[(19.75±2.22) U/ml, (23.92±2.53) U/ml, (27.23±2.67) U/ml] were significantly higher than those in the MPP model group(P<0.05). Conclusion: This suggests that curcumin chitosan nanoparticles may be suitable for antioxidant treatment of mycoplasma pneumoniae in mice, and can dose-dependently inhibit the release of oxygen free radicals in the lung tissue of MPP mice. This finding may offer a new avenue for the development of therapeutic drug carriers for MPP.
Abstract：Objective: Curcumin(Cur) and Chitosan(CS) were utilized as primary components for the production of curcumin chitosan nanoparticles. The impact of these nanoparticles on oxidative stress in mycoplasma pneumoniae-infected mice was assessed. Methods: The drug loading and entrapment efficiency of Cur-CS nanoparticles were determined for various feeding ratios, and the release profiles of Cur-CS nanoparticles in different release media were investigated using the dynamic membrane dialysis method. The mycoplasma pneumoniae pneumonia(MPP) mouse model was created through the infection of mice with mycoplasma pneumoniae. The mice were then allocated randomly into five groups: a blank control group, an MPP model group, a low Cur-CS dose group, a middle Cur-CS dose group, and a high Cur-CS dose group, each consisting of 7 mice. The study compared the levels of antioxidant enzymes and phospholipid peroxide content in the lung tissue of mice across various experimental groups. Results: The findings indicated that the drug loading of nanoparticles escalated from 2.10% to 11.74% as the feed ratio of Cur to CS increased from 1∶ 20 to 1∶ 2.5. Concurrently, as drug loading increased, the entrapment efficiency of nanoparticles decreased from 85.33% to 58.92%. The cumulative release rate of Cur was 95.3% after 24 h, whereas the cumulative release rate of Cur-CS nanoparticles was only 94.3% after 48 h. Analysis of the lung tissue samples indicated that the levels of SOD [(76.17±9.36) U/ml, (86.23±10.09) U/ml, (98.06±11.12) U/ml] and GSH-Px[(19.75±2.22) U/ml, (23.92±2.53) U/ml, (27.23±2.67) U/ml] were significantly higher than those in the MPP model group(P<0.05). Conclusion: This suggests that curcumin chitosan nanoparticles may be suitable for antioxidant treatment of mycoplasma pneumoniae in mice, and can dose-dependently inhibit the release of oxygen free radicals in the lung tissue of MPP mice. This finding may offer a new avenue for the development of therapeutic drug carriers for MPP.
FU Jin-hua. Preparation of Curcumin Chitosan Nanoparticles and Its Effect on Free Radical Injury in Mice with Mycoplasma Pneumoniae Pneumonia[J]. 中国生物医学工程学报(英文版）, 2023, 32(3): 100-108.
FU Jin-hua. Preparation of Curcumin Chitosan Nanoparticles and Its Effect on Free Radical Injury in Mice with Mycoplasma Pneumoniae Pneumonia. Chinese Journal of Biomedical Engineering, 2023, 32(3): 100-108.
[1] Zhang L, Xiao Y, Zhang G, et al.Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study[J]. BMC Infect Dis, 2023,23(1):231. [2] Kurkela S, Puolakkainen M, Hokynar K, et al.Mycoplasma pneumoniae outbreak, Southeastern Finland, 2017-2018: molecular epidemiology and laboratory diagnostic lessons[J]. Eur J Clin Microbiol Infect Dis, 2019,38(10):1867-1871. [3] Kenri T, Yamazaki T, Ohya H, et al.Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains[J]. Front Microbiol, 2023,14:1202357. [4] Jiang TT, Sun L, Wang TY, et al.The clinical significance of macrolide resistance in pediatric mycoplasma pneumoniae infection during COVID-19 pandemic[J]. Front Cell Infect Microbiol, 2023,13:1181402. [5] Huang XL, Wei XC, Guo LQ, et al.The therapeutic effects of Jaceosidin on lipopolysaccharide-induced acute lung injury in mice[J]. J Pharmacol Sci, 2019,140(3):228-235. [6] Zhu X, Quan YY, Yin ZJ, et al.Sources, morphology, phytochemistry, pharmacology of Curcumae Longae Rhizoma, Curcumae Radix, and Curcumae Rhizoma: a review of the literature[J]. Front Pharmacol, 2023,14:1229963. [7] Zakaria MY, Sharaky M, Noreddin AM, et al.Investigating the superiority of chitosan/ D-alpha-tocopheryl polyethylene glycol succinate binary coated bilosomes in promoting the cellular uptake and anti-SARS-CoV-2 activity of polyphenolic herbal drug candidate[J]. Int J Pharm, 2023:123385. [8] Alqahtani LS, Abd-Elhakim YM, Mohamed AA, et al.Curcumin-loaded chitosan nanoparticles alleviate fenpropathrin-induced hepatotoxicity by regulating lipogenesis and pyroptosis in rats[J]. Food Chem Toxicol, 2023:114036. [9] Pistone A, de Gaetano A, Piperopoulos E, et al. Effect of sodium hydroxide and tripolyphosphate on curcumin release from chitosan-based macroparticles[J]. Materials (Basel), 2023,16(17):5850. [10] Jiang M, Gan Y, Li Y, et al.Protein-polysaccharide-based delivery systems for enhancing the bioavailability of curcumin: A review[J]. Int J Biol Macromol, 2023,250:126153. [11] Luangapai F, Iwamoto S.Influence of blending and layer-by-layer assembly methods on chitosan-gelatin composite films enriched with curcumin nanoemulsion[J]. Int J Biol Macromol, 2023,249:126061. [12] Thirupathi A, Guzzatti M, Corrêa M, et al.Green synthesis of gold nanoparticles with curcumin or Açai in the tissue repair of palatal wounds[J]. Antioxidants (Basel), 2023,12(8):1574. [13] Gao C, Chu X, Gong W, et al.Retraction note: Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease[J]. J Nanobiotechnology, 2023,21(1):296. [14] Bapat RA, Bedia SV, Bedia AS, et al.Current appraises of therapeutic applications of nanocurcumin: A novel drug delivery approach for biomaterials in dentistry[J]. Environ Res, 2023:116971. [15] Peng Lin, Li Lifeng, Han Gang, et al.Preparation and properties of carboxymethyl chitosan nanoparticles loaded with curcumin[J]. Chinese Journal of Pharmaceuticals, 2016,47(02):178-182. (彭琳, 李利锋, 韩刚,等. 载姜黄素羧甲基壳聚糖纳米粒的制备和性能[J]. 中国医药工业杂志,2016,47(02):178-182.) [16] Yang C, Wang X, Yao X, et al.Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery[J]. J Control Release, 2015,205:206-217. [17] Chen De, Liu Yi, Fan Kai-yan, et al.Relation between drug release and the drug status within curcumin-loaded microsphere[J]. Acta Pharmaceutica Sinica, 2016,51(01):140-146. (陈德, 刘意, 范凯燕,等. 姜黄素微球中药物存在形式与释药行为的关系研究[J]. 药学学报,2016,51(01):140-146.) [18] National Pharmacopoeia Committee.Pharmacopoeia of the People's Republic of China: Four Volumes [M]. Beijing: China Medical Science and Technology Press, 2015:120-124. (国家药典委员会.中华人民共和国药典:四部[M].北京:中国医药科技出版社,2015:120-124.) [19] Li Yan, Luo Cheng, Zhou Jie.Recent advances of nanoprecipitation and its applications in nano-drug carriers[J]. Chinese Journal of Biomedical Engineering, 2017,36(4):483-489. (李艳, 罗成, 周婕. 纳米沉淀法及其在纳米药物载体领域的应用研究进展[J]. 中国生物医学工程学报,2017,36(4):483-489.) [20] Takanashi A, Pouton CW, Al-Wassiti H.Delivery and expression of mRNA in the secondary lymphoid organs drive immune responses to lipid nanoparticle-mRNA vaccines after intramuscular injection[J]. Mol Pharm, 2023,20(8):3876-3885. [21] Sobrevilla-Hernández G, Franco-Molina MA, Zárate-Trivio DG, et al.Development of a new generation of miniemulsion based on cottonseed oil with α-tocopherol and ZnO and evaluation of its adjuvant activity[J]. PeerJ, 2023,11:e14981. [22] Zhao Z, Peng Y, Shi X, et al.Chitosan derivative composite nanoparticles as adjuvants enhance the cellular immune response via activation of the cGAS-STING pathway[J]. Int J Pharm, 2023,636:122847. [23] Adelnia H, Moonshi SS, Wu Y, et al.A bioactive disintegrable polymer nanoparticle for synergistic vascular anticalcification[J]. ACS Nano, 2023,17(19):18775-18791. [24] Bharti Sharma J, Bhatt S, Tiwari A, et al.Statistical optimization of tetrahydrocurcumin loaded solid lipid nanoparticles using Box Behnken design in the management of streptozotocin-induced diabetes mellitus[J]. Saudi Pharm J, 2023,31(9):101727. [25] Shang J, Liu Y, Kang J, et al.Structure and characterization of Tremella fuciformis polysaccharides/whey protein isolate nanoparticles for sustained release of curcumin[J]. J Sci Food Agric, 2023. [26] Yong HW, Ferron M, Mecteau M, et al.Single functional group platform for multistimuli responsivities: Tertiary amine for CO(2)/pH/ROS-triggered cargo release in nanocarriers[J]. Biomacromolecules, 2023,24(9):4064-4077. [27] Izak-Nau E, Niggemann LP, Göstl R.Brownian relaxation shakes and breaks magnetic iron oxide-polymer nanocomposites to release cargo[J]. Small, 2023:e2304527. [28] Luo X, Su D, Lu N, et al.Physicochemical properties of a novel chiral self-assembling peptide R-LIFE-1 and its controlled release to exosomes[J]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2023,40(4):770-777.
